Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03793062 · ClinicalTrials.gov registry record

Genetic and Epigenetic Basis of Chronic Wounds

A clinical trial of Chronic Wounds, sponsored by University of Pittsburgh.

Recruiting
Registry status
256
Enrollment target
1
Study location

NCT03793062 is a study of Chronic Wounds that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 256 participants, above the 121-participant average among 4 other Chronic Wounds trials with a reported enrollment target (112% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03793062, a study of Chronic Wounds, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
256 participants
Enrollment target
1
Study location

Study Summary

This pilot study is designed for chronic wounds that fail to heal in a timely manner carry specific genetic signatures. These genetic signatures will be studied using debrided wound tissue that is removed by the wound care provider as part of standard of care. The reference genomic signature will be evaluated by obtaining blood samples and will be compared with wound debrided tissue genomic signature to understand wound specific genomic changes.

Conditions Studied

Interventions

  • OTHER No Interventions

Study Locations (1)

Pennsylvania

  • UPMC Wound Care Centers - Pittsburgh

Trial Details

FieldValue
Enrollment Target 256 participants
Start Date 2018-12-04
Est. Completion 2028-12-31

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT03793062

The ClinicalTrials.gov registry entry for NCT03793062 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 256 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 121-participant average among 4 other Chronic Wounds trials with a reported enrollment target (112% higher). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Wounds appearing as the primary indexed condition, and to 1 intervention - of which No Interventions is the first listed.

NCT03793062 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03793062 about?

NCT03793062 is a clinical study titled "Genetic and Epigenetic Basis of Chronic Wounds". This pilot study is designed for chronic wounds that fail to heal in a timely manner carry specific genetic signatures. These genetic signatures will be studied using debrided wound tissue that is removed by the wound care provider as part of standard of care. The reference genomic signature will be...

What is the current status of trial NCT03793062?

This trial is currently recruiting. The enrollment target is 256 participants. The study started on 2018-12-04. Estimated completion is 2028-12-31.

What conditions does trial NCT03793062 study?

This clinical trial studies the following conditions: Chronic Wounds.

What interventions are being tested in trial NCT03793062?

The interventions under investigation include: No Interventions (OTHER).

Who is sponsoring clinical trial NCT03793062?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03793062 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Wounds

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.